Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Construction Partners
ROAD
$6.86B
| $845K | ﹤0.01% |
50,050
+10,818
| +28% | +$190K |
|
2652
Allient
ALNT
$1.94B
| $841K | ﹤0.01% |
26,000
+1,205
| +5% | +$33.6K |
|
2653
Goldgroup Mining Inc.
GORO
$184M
| $841K | ﹤0.01% |
151,650
+4,928
| +3% | +$21.5K |
|
|
CATC
2654
DELISTED
CAMBRIDGE BANCORP
CATC
| $840K | ﹤0.01% |
10,473
+323
| +3% | +$25.2K |
|
|
MEET
2655
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $839K | ﹤0.01% |
167,361
-6,990
| -4% | -$32.9K |
|
2656
Citizens & Northern Corp
CZNC
$459M
| $837K | ﹤0.01% |
29,606
| – | – |
|
|
DSPG
2657
DELISTED
DSP Group Inc
DSPG
| $835K | ﹤0.01% |
53,020
+1,421
| +3% | +$20.9K |
|
2658
NVE Corp
NVEC
$565M
| $834K | ﹤0.01% |
11,676
+87
| +0.8% | +$5.67K |
|
|
SIEN
2659
DELISTED
Sientra, Inc.
SIEN
| $833K | ﹤0.01% |
9,317
-878
| -9% | -$66.2K |
|
2660
Forum Energy Technologies
FET
$934M
| $832K | ﹤0.01% |
24,751
+279
| +1% | +$7.56K |
|
2661
Alico
ALCO
$307M
| $826K | ﹤0.01% |
23,027
+220
| +1% | +$7.4K |
|
|
KIN
2662
DELISTED
Kindred Biosciences, Inc.
KIN
| $822K | ﹤0.01% |
96,845
+9,902
| +11% | +$77.3K |
|
|
SBT
2663
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $821K | ﹤0.01% |
101,285
+1,037
| +1% | +$9.64K |
|
2664
Daily Journal
DJCO
$771M
| $816K | ﹤0.01% |
2,807
+33
| +1% | +$9.23K |
|
2665
Willdan Group
WLDN
$1.28B
| $815K | ﹤0.01% |
25,642
| – | – |
|
2666
Inseego
INSG
$84.9M
| $814K | ﹤0.01% |
11,095
+435
| +4% | +$25.1K |
|
|
PRTK
2667
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $811K | ﹤0.01% |
201,028
+8,145
| +4% | +$28.3K |
|
2668
Primis Financial Corp
FRST
$405M
| $810K | ﹤0.01% |
49,509
+1,640
| +3% | +$25.9K |
|
2669
Biglari Holdings Class B
BH
$1.2B
| $807K | ﹤0.01% |
7,050
+733
| +12% | +$74.7K |
|
2670
RBB Bancorp
RBB
$458M
| $807K | ﹤0.01% |
38,107
+384
| +1% | +$7.8K |
|
|
AKRO
2671
DELISTED
Akero Therapeutics
AKRO
| $804K | ﹤0.01% |
36,224
+3,935
| +12% | +$81.4K |
|
2672
EverQuote
EVER
$884M
| $799K | ﹤0.01% |
23,246
| – | – |
|
2673
Cue Biopharma
CUE
$119M
| $797K | ﹤0.01% |
1,673
+51
| +3% | +$16K |
|
2674
Comstock Resources
CRK
$4.23B
| $788K | ﹤0.01% |
95,627
+4,193
| +5% | +$29.3K |
|
2675
Teekay
TK
$983M
| $786K | ﹤0.01% |
147,560
+4,692
| +3% | +$23.2K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.